Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Zimmer to Distribute Rotator Cuff Patch

By HospiMedica staff writers
Posted on 23 Oct 2003
An exclusive, multi-year worldwide agreement to distribute a nonresorbable biologic patch for the repair of rotator cuff injuries has been announced by Zimmer Holdings, Inc. More...
(Warsaw, IN, USA).

The patch, called the Permacol Surgical Implant, was developed and is manufactured by Tissue Science Laboratories plc (Aldershot, UK). The implant is a chemically cross-linked acellular sheet of collagen/elastin that is processed from porcine dermis. It has been available in the UK for rotator cuff repairs since 2002 and had previously been cleared by the US Food and Drug Administration (FDA) for incontinence treatments, hernia repairs, and plastic and reconstructive surgery of the head and face.

"With the Permacol product, we will be able to address the needs of orthopedic surgeons who need to augment their surgical repairs or who need a material to bridge massive tears that are not able to be sutured together,” said Ray Elliot, chairman, president, and CEO of Zimmer. The company states that it believes the Permacol implant may offer several advantages over current products or treatments, including greater long-term stability and better inflammatory response characteristics, due to the proprietary processing technology used by Tissue Science Laboratories. Zimmer already participates in the shoulder repair market with Bigliani-Flatow, a total shoulder replacement system.





Related Links:
Zimmer
Tissue Science

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Endoscopy Display
E190
Mammo DR Retrofit Solution
DR Retrofit Mammography
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.